4//SEC Filing
David Glenn 4
Accession 0001555280-22-000114
CIK 0001555280other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 6:34 PM ET
Size
16.6 KB
Accession
0001555280-22-000114
Insider Transaction Report
Form 4
Zoetis Inc.ZTS
David Glenn
SVP and Acting CFO
Transactions
- Exercise/Conversion
Common Stock
2022-02-23$46.09/sh+7,712$355,446→ 54,284 total - Sale
Common Stock
2022-02-23$189.95/sh−19,415$3,687,879→ 52,501 total - Sale
Common Stock
2022-02-23$190.70/sh−5,929$1,130,660→ 46,572 total - Exercise/Conversion
Stock Option
2022-02-23−7,712→ 75,351 total→ Common Stock (7,712 underlying) - Exercise/Conversion
Common Stock
2022-02-23$87.51/sh+24,678$2,159,572→ 78,962 total - Sale
Common Stock
2022-02-23$188.95/sh−7,046$1,331,342→ 71,916 total - Exercise/Conversion
Stock Option
2022-02-23−24,678→ 50,673 total→ Common Stock (24,678 underlying)
Footnotes (10)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2021.
- [F10]24,678 options granted February 12, 2019 at an exercise price of $87.51 per option.
- [F2]The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.44 to $189.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.44 to $190.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.44 to $191.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
- [F6]7,712 options granted February 27, 2015 at an exercise price of $46.09 per option.
- [F7]Each option vests on the third anniversary of the date of grant.
- [F8]Each option expires on the tenth anniversary of the date of grant.
- [F9]18,794 options granted February 11, 2020 at an exercise price of $144.03 per option; 18,326 options granted February 10, 2021 at an exercise price of $160.62 per option; and 13,553 options granted February 8, 2022 at an exercise price of $201.30 per option.
Documents
Issuer
Zoetis Inc.
CIK 0001555280
Entity typeother
Related Parties
1- filerCIK 0001606256
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 6:34 PM ET
- Size
- 16.6 KB